Compare SOLS & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SOLS | PEN |
|---|---|---|
| Founded | 2025 | 2004 |
| Country | United States | United States |
| Employees | 4400 | N/A |
| Industry | Aerospace | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 12.8B |
| IPO Year | N/A | 2015 |
| Metric | SOLS | PEN |
|---|---|---|
| Price | $82.02 | $325.83 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 16 |
| Target Price | $79.25 | ★ $360.14 |
| AVG Volume (30 Days) | ★ 1.6M | 479.8K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | ★ 0.39% | N/A |
| EPS Growth | N/A | ★ 1155.56 |
| EPS | N/A | ★ 4.52 |
| Revenue | N/A | ★ $1,403,665,000.00 |
| Revenue This Year | $6.36 | $14.34 |
| Revenue Next Year | $5.64 | $13.71 |
| P/E Ratio | ★ $54.31 | $71.86 |
| Revenue Growth | N/A | ★ 17.50 |
| 52 Week Low | $40.43 | $221.26 |
| 52 Week High | $84.44 | $362.41 |
| Indicator | SOLS | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 57.33 | 38.48 |
| Support Level | $77.82 | $302.19 |
| Resistance Level | $83.53 | $335.61 |
| Average True Range (ATR) | 3.06 | 2.91 |
| MACD | -0.36 | -0.36 |
| Stochastic Oscillator | 74.78 | 16.91 |
Solstice Advanced Materials is a diversified specialty chemicals company created in late 2025 after being spun off from Honeywell. It sells chemicals and materials to a wide range of end markets. Its largest product category is refrigerants used in heating, ventilation and air conditioning systems, and autos, where Solstice sells low global warming potential refrigerants. The company also sells materials used for building and construction, semiconductor production, healthcare packaging, and defense. Additionally, Solstice runs the only US uranium conversion business currently in operation.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.